These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 35131168)
21. Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus. Nowak N; Hohendorff J; Solecka I; Szopa M; Skupien J; Kiec-Wilk B; Mlynarski W; Malecki MT Endocrine; 2015 Dec; 50(3):643-9. PubMed ID: 25987348 [TBL] [Abstract][Full Text] [Related]
22. Molecular diagnosis of maturity-onset diabetes of the young in a cohort of Chinese children. Xu A; Lin Y; Sheng H; Cheng J; Mei H; Ting TH; Zeng C; Liang C; Zhang W; Li C; Li X; Liu L Pediatr Diabetes; 2020 May; 21(3):431-440. PubMed ID: 31957151 [TBL] [Abstract][Full Text] [Related]
23. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing. López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393 [TBL] [Abstract][Full Text] [Related]
24. Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels. Ping F; Fu J; Xiao X Front Endocrinol (Lausanne); 2022; 13():1024431. PubMed ID: 36387841 [TBL] [Abstract][Full Text] [Related]
25. Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families. Barrio R; Bellanné-Chantelot C; Moreno JC; Morel V; Calle H; Alonso M; Mustieles C J Clin Endocrinol Metab; 2002 Jun; 87(6):2532-9. PubMed ID: 12050210 [TBL] [Abstract][Full Text] [Related]
26. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1. Johansen A; Ek J; Mortensen HB; Pedersen O; Hansen T J Clin Endocrinol Metab; 2005 Aug; 90(8):4607-14. PubMed ID: 15928245 [TBL] [Abstract][Full Text] [Related]
27. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2). Spégel P; Ekholm E; Tuomi T; Groop L; Mulder H; Filipsson K Diabetes; 2013 Feb; 62(2):653-61. PubMed ID: 23139355 [TBL] [Abstract][Full Text] [Related]
28. A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY. Bishay RH; Greenfield JR Med J Aust; 2016 Nov; 205(10):480-485. PubMed ID: 27852188 [TBL] [Abstract][Full Text] [Related]
29. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential. Østoft SH Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089 [TBL] [Abstract][Full Text] [Related]
30. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Hattersley AT Diabet Med; 1998 Jan; 15(1):15-24. PubMed ID: 9472859 [TBL] [Abstract][Full Text] [Related]
31. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes. Ming-Qiang Z; Yang-Li D; Ke H; Wei W; Jun-Fen F; Chao-Chun Z; Guan-Ping D J Pediatr Endocrinol Metab; 2019 Jul; 32(7):759-765. PubMed ID: 31216263 [TBL] [Abstract][Full Text] [Related]
32. The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young. Bacon S; Schmid J; McCarthy A; Edwards J; Fleming A; Kinsley B; Firth R; Byrne B; Gavin C; Byrne MM Am J Obstet Gynecol; 2015 Aug; 213(2):236.e1-7. PubMed ID: 25935773 [TBL] [Abstract][Full Text] [Related]
33. A novel genetic mutation in a Portuguese family with GCK-MODY. Almeida C; Silva SR; Garcia E; Leite AL; Teles A; Campos RA J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):129-33. PubMed ID: 23843579 [TBL] [Abstract][Full Text] [Related]
34. Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients. Wędrychowicz A; Tobór E; Wilk M; Ziółkowska-Ledwith E; Rams A; Wzorek K; Sabal B; Stelmach M; Starzyk JB J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):246-252. PubMed ID: 28663157 [TBL] [Abstract][Full Text] [Related]
35. Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4alpha, GCK and HNF-1alpha. Pruhova S; Ek J; Lebl J; Sumnik Z; Saudek F; Andel M; Pedersen O; Hansen T Diabetologia; 2003 Feb; 46(2):291-5. PubMed ID: 12627330 [TBL] [Abstract][Full Text] [Related]
36. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis. Karaoglan M; Nacarkahya G J Diabetes; 2021 Feb; 13(2):154-163. PubMed ID: 32710514 [TBL] [Abstract][Full Text] [Related]
37. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation. Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223 [TBL] [Abstract][Full Text] [Related]
38. Coinheritance of HNF1A and glucokinase variants in maturity-onset diabetes of the young. Watanabe D; Yagasaki H; Narusawa H; Inukai T Endocrinol Diabetes Metab Case Rep; 2024 Jul; 2024(3):. PubMed ID: 39089324 [TBL] [Abstract][Full Text] [Related]
39. Diagnosis of MODY in the offspring of parents with insulin-dependent and non-insulin-dependent diabetes mellitus. Guazzarotti L; Fumelli P; Testa I; Pecora R; Panicari F; Bellanné-Chantelot C; Bartolotta E J Pediatr Endocrinol Metab; 2001; 14 Suppl 1():611-7. PubMed ID: 11393552 [TBL] [Abstract][Full Text] [Related]
40. Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations. Franco LF; Szarf G; Dotto RP; Dib SA; Moises RS; Giuffrida FMA; Reis AF Diabetes Res Clin Pract; 2021 Jun; 176():108867. PubMed ID: 34023340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]